InjectableCellTherapyforDegenerativeDiscDisease：椎间盘退变性疾病的可注射的细胞疗法.pptVIP

下载本文档

5
0
约2.7千字
约 9页
2018-06-30 发布于浙江
举报
版权申诉

InjectableCellTherapyforDegenerativeDiscDisease：椎间盘退变性疾病的可注射的细胞疗法.ppt

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

InjectableCellTherapyforDegenerativeDiscDisease：椎间盘退变性疾病的可注射的细胞疗法

Injectable Cell Therapy for Degenerative Disc Disease Richard Melpignano Degenerative Disc Disease The natural degeneration of the Intervertebral Discs (IVD) and nucleus pulposus (NP), which is the spinal cord’s jelly-like shock absorber Most commonly affects lumbar cervical regions in older patients Can lead to Osteoarthritis (the breakdown of protective cartilage), herniated discs, and spinal stenosis Treatment Injection of NP cells inside a liquid suspension directly into IVD Purpose is to promote tissue regeneration Current liquid delivery medium is ineffective; can only hold cells in place for 3-4 days Advancements In July 2013, Researchers from Duke University created a new biomaterial suspension for NP injection Made up of the chemically modified protein laminin-111 and two polyethylene glycol hydrogels Injected as a liquid and quickly forms into a gel Gel mimics laminin (protein native to NP). This ensures persistence and biosynthesis of the injected NP cells Procedure All three substances are injected directly into affected IVD Takes about a minute to inject, 5 minutes to begin to solidify, and 20 minutes to completely set Results Luciferase biomarkers used to track migration of injected cells Two weeks after injection, significantly more cells remained in place when delivered within the biomaterial suspension in comparison to the traditional liquid suspension Future Still much work to be done; not yet practical for use on humans Injection sites are still not large enough to deliver NP cells to larger IVD sites that are present in humans (in comparison to mice used in tests) Additional studies that evaluate disc height or matrix hydration following cell delivery would further optimize this treatment Works Cited Aubrey T. Francisco, Robert J. Mancino, Robby D. Bowles, Jonathan M. Brunger, David M. Tainter, Yi-Te Chen, William J. Richardson, Farshid Guilak, Lori A. Setton, Injectable laminin-functionalized hydrogel for nucleus pulposus regeneration, B